Respiratory Research & Clinical Practice
Brief Background
|
The Respiratory Research & Clinical Practice (RRCP) ISSN 3086-3910 (formerly Jornal Brasileiro de Pneumologia ISSN 1806-3756) is a continuous publication of the Sociedade Brasileira de Pneumologia e Tisiologia – SBPT since 1975. Its short title, Respir. Res. & Clin. Pract., should be used in bibliographies, footnotes, and bibliographic references and legends. The mission of Respiratory Research & Clinical Practice is to publish and disseminate high-quality scientific research in respiratory medicine, pulmonology, thoracic diseases, intensive care, and related fields, promoting education, innovation, and evidence-based clinical practice. As Jornal Brasileiro de Pneumologia, we were indexed in SciELO in 2002, in PubMed since 2006, and in Clarivate Web of Science since 2009, becoming a recognized reference in respiratory medicine. On October 18, 2025, the journal celebrated 50 years of uninterrupted publication, preserving its editorial legacy while projecting it into the future through Respiratory Research & Clinical Practice. Throughout this trajectory, the journal has maintained its editorial quality and publication regularity. The main change was the adoption of an English title as a strategy for internationalization; however, its scope, scientific commitment, and editorial content remain unchanged. It also stands out as one of the few scientific journals produced in Brazil with an impact factor of 3.0 that charges no submission or publication fees to authors. The journal seeks to promote the advancement of scientific knowledge, encourage innovation, support continuing medical education, and contribute to evidence-based clinical practice, with both national and international reach. Frequency: Continuous Publication - Bimonthly Areas of interest: As an international online journal, Respiratory Research & Clinical Practice covers all clinical and translational areas and topics of respiratory medicine in adults and the pediatric population. Indexing sources:
The journal has open and free access. No fees are required for readers and there are no article processing charges for authors. |
Open Access
|
The Respiratory Research & Clinical Practice (formerly the Jornal Brasileiro de Pneumologia) follows the Open Access model, providing virtual access to all scientific texts published by the journal, unless otherwise specified. Open Access is the condition where the copyright holder of a scholarly work grants usage rights to others using an open license (Creative Commons Attribution, CC-BY 4.0) allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose. |
Open Science Compliance
|
As a good practice, following Open Science to ensure security and transparency, the Respiratory Research & Clinical Practice encourages the ‘sharing of the data, codes, methods and other materials used and resulting from research that generally underlie the texts of articles published by journals’. Respiratory Research & Clinical Practice is a Diamond Open Access journal. Manuscript submission is continuous throughout the year and completely free. Access, reading, downloading, citing, copying, distributing, printing, etc. full published manuscripts are also free, without prior permission from the editors or authors. Correct references to the journal must be provided in the citing material. During the submission, authors must inform about the study's compliance with Open Science communication practices by filling in the Form available here. It is recommended that all content underlying the text of the manuscript be made available either during the submission or in open access repositories. The cited data must be referenced in the article together with the bibliographic references, indicating the location address of the file/s in the repository. In the case of data restricted by legal and/or ethical issues, the reason for the restriction and the contact responsible for providing the information must be informed. All authors must complete the Open Science Compliance Form, in which authors share with the journal information about the manuscript in accordance with Open Science communication practices. |
Ethics in Publication
|
Respiratory Research & Clinical Practice is rigorously committed to good practices in scientific publication and follows international standards in resolving ethical issues in publication. The journal adheres to the guidelines of COPE, Equator Network, ICMJE and the Good Practice Guide for Strengthening Ethics in Scientific Publication for the analysis of possible cases of misconduct in publication, including guidelines on data presentation, authorship, conflicts of interest, privacy and consent. |
Focus and Scope
|
The Respiratory Research & Clinical Practice publishes and disseminates high-quality scientific research in respiratory medicine and related fields, covering both clinical and translational research. |
Digital Preservation
|
This journal follows the standards defined in the SciELO Program's Digital Preservation Policy. |
Indexing Sources
Bibliographic Journal Information
|
Websites and Social Media
Preprints
|
The RRCP accepts submissions of articles deposited on preprint servers (SciELO Preprints). The manuscripts previously submitted to preprint repositories will be accepted and will undergo the same Peer Review Process adopted by the journal. For more details on repositories, please refer to the Open Data section below in this document. |
Peer Review Process
|
This journal adopts the double-blind peer review process, in which authors and reviewers do not know each other's identity. Therefore, the files with the identification of the authors must be submitted separately from the other files. The process includes the following steps: - Screening by the editorial assistance: upon receipt, the article is checked against the journal's requirements (if it is written in English, type of article, registration numbers, author data, references in Vancouver, etc.). Otherwise, the manuscript is returned for adjustments. If the article complies with the standards, it is assigned to the Editor-in-Chief or Associate Editor according to the topic of the article. The CrossRef Similarity Check (iThenticate) software is used on all manuscripts submitted to the Respiratory Research & Clinical Practice. In case of multiple submission, a notification is sent to the Editor-in-Chief who will analyze the possibility of rejecting the article before sending it to the Associate Editor. - Initial Screening by the Associate Editor assigned according to the subject area of the article: the manuscript is checked if complies with the scope and quality standards of the journal. Manuscripts that do not meet these criteria are rejected in the initial phase. Otherwise, the manuscript is sent to be assessed by at least two peer reviewers. - Double-blind peer review: reviewers assess the manuscript anonymously and submit their opinions through the system. In cases of preprint, it is not possible to guarantee the anonymity of the authors. Based on these opinions, the Associate Editor makes a recommendation for reject, review or accept the article. - Editor's evaluation with the reviewers' opinions: The decision of the Associate Editor on the first version of the article is sent to the authors: reject or review. If the opinions indicate that the article has methodological gaps that would not be remedied in a new version, the article is rejected. If the manuscript receives a review recommendation, authors have up to 30 days to send the revised version of the article, explaining and pointing out the changes made. New versions of the article may be requested. If the authors do not comply with the requests made by the reviewers and the editor, the article may be rejected. This decision is communicated to the Editor-in-Chief who can ratify or refute this decision.
Our average turnaround time for the first response to the authors is 30 days, although a longer period may be needed. After this evaluation, the editors will decide on acceptance, minor review, major review, rejection and resubmission or rejection. - Article is accepted: as soon as the Associate Editor accepts the article, the authors will be notified of the decision by e-mail. - PDF approval and publication: Authors will receive an email to make final corrections and approve the final PDF file of the article. Corrections requested at this stage of the process should be limited to typographical errors and should not involve changes in the content of the study or in the list of authors. Authors must return the approved version by email within 48 hours of receiving the message. After the approval, the article will be submitted for publication. The opinions expressed in the articles, including the changes requested by the reviewers, will solely be the responsibility of the authors. In all approved manuscripts the journal will declare the name of the Associate Editor responsible for the evaluation process. After final approval all manuscripts receive a persistent identification number – DOI. |
Open Data
|
When submitting the manuscript, the authors must attach a copy of the Open Science Compliance Form. To promote transparency, upon manuscript submission, authors must declare the availability of their data, including analysis datasets, instruments, statistical analysis scripts, protocols, and supplementary materials. These materials should be made available in open online repositories, such as SciELO Data, Zenodo, Figshare, OSF, or Mendeley Data, when they cannot be published within the article itself. This information must be indicated in the manuscript. Therefore, we request that all datasets associated with submitted manuscripts be accompanied by the Open Science Compliance Form. If the data are not available for access or are not suitable for publication, authors will have the opportunity to describe the reason during the submission process, stating, for example, that the research data are confidential. This statement will appear alongside the published article. |
Fees
|
The journal is completely free to access, with no article processing charges. There are no fees for submission, processing, or publishing. Financial Sustainability Sociedade Brasileira de Pneumologia e Tisiologia (SBPT) maintains Respiratory Research & Clinical Practice and will retain the responsibility for the maintenance of the journal. Grants from governmental funding agencies partially fund the journal (i.e., Conselho Nacional de Desenvolvimento Científico e Tecnológico [CNPq] - Brasil). This journal has no other financial support. |
Ethics and Misconduct, Correction and Retraction Policy
|
Regarding ethical issues, misconduct, and responsibility, the journal recommends adhering to ethical standards and responsibilities in academic communication as established by national and international institutions, such as:
Correction For erratum the journal issues only in the case of reconsideration of information related to the methods and results of the published article. Errata are not issued in the case of adjustments to the title, authors' names, institutional affiliations, authors' abbreviations, Orcid ID, or acknowledgements and collaborations. This information should be checked by the authors when they receive the editorial decision and the final PDF of the article. Retraction Policy Retractions will be used in cases of redundant publication, plagiarism, peer review manipulation, reuse of material or data without authorization, copyright infringement or some other legal issue (eg, libel, privacy, illegality), unethical research or a failure to disclose a major competing interest: https://publicationethics.org/guidance/guideline/retraction-guidelines. Retraction will be partial when the misconduct applies to a specific part of the article, without, however, compromising the set of published research. If only a small part of an article reports flawed data or content, will be rectified by a correction. Ethical issues and/or issues that may the reputation of the journal will be evaluated and addressed by the Editorial Board. |
Policy on Conflict of Interest
|
Conflicts of interest may be personal, commercial, political, academic, or financial in nature. Conflicts of interest may arise when authors, reviewers, or editors have interests that could influence the preparation or evaluation of manuscripts. Upon manuscript submission, authors are responsible for disclosing any financial or other relationships that may have influenced their work. If there is any actual or potential conflict of interest, the author(s) must disclose it in a signed document and upload it to the submission platform. For additional information, please refer to: Disclosure of Financial and Non-Financial Relationships and Activities, and Conflicts of Interest. Declaration of conflict of interest - The conflicts of interest of all authors must be disclosed on the title page of the manuscript. Authors should download the appropriate form download it at https://rrcpjournal.org/wp-content/uploads/sites/17/2026/02/copyright_2026.pdf and, after signing, the authors should upload it during the submission process. |
Adoption of Similarity Software
|
Any contributions submitted must be original, and the manuscript, nor any part of it, must not be under consideration by any other journal. In addition, authors should not submit the same manuscript in different languages to different journals. Authors must declare any publications that may coincide at the time of submission for appreciation and evaluation by the editor. All manuscripts, after peer review process, are submitted to the manuscripts plagiarism detection tools (iThenticate) to detect any duplication, redundant publication or misconduct. All text that is similar or does not indicate the respective citation/reference will be evaluated regardless of the percentage of similarity or plagiarism. Whenever any of these situations are detected, the Editor-in-Chief will contact the authors and their institutions. If the editor identifies a situation of plagiarism, the authors will be subject to immediate rejection of the submitted manuscript. If the editor is unaware of the situation when accepting the manuscript, there will be a retraction in subsequent edition of the journal. |
Adoption of Software Using Artificial Intelligence Resources
|
The submission and publication of content created by artificial intelligence, language models, machine learning, or similar technologies is discouraged, unless part of the formal research design or methods. Authors should disclose the use of AI-assisted technologies in the writing process by adding a statement at the end of the manuscript. The statement should be in the following format: “During the preparation of this manuscript, the authors used [Name of the tool] for [Reason of use]. After using this tool, the authors have reviewed and edited the content and take full responsibility for the content of the publication”. The journal supports the recommendations of the World Association of Medical Editors (WAME - https://wame.org/page3.php?id=106) on the ethical considerations related to the use of these technologies. There is no need to make this declaration for the use of basic tools for checking grammar, spelling and bibliographical references. |
Gender and Sex Issues
|
The editorial team of Respiratory Research & Clinical Practice, as well as the authors who publish in the journal, must always comply with the Sex and Gender Equity in Research (SAGER) guidelines: https://ease.org.uk/wp-content/uploads/2023/01/EASE-SAGER-Checklist-2022.pdf. The SAGER guidelines provide recommendations for reporting sex and gender information in study design, data analysis, results and interpretation of findings. Respiratory Research & Clinical Practice strives for gender equity on its editorial board, acknowledging the male predominance in the field. |
Ethics Committee
|
Respiratory Research & Clinical Practice is rigorously committed to good practices in scientific publication and follows international standards in resolving ethical issues in publication. The journal adheres to the guidelines of COPE, Equator Network, ICMJE and the Good Practice Guide for Strengthening Ethics in Scientific Publication for the analysis of possible cases of misconduct in publication, including guidelines on data presentation, authorship, conflicts of interest, privacy and consent. |
Copyright
|
Authors of articles published by Respiratory Research & Clinical Practice retain the copyright of their works, licensing them under the Creative Commons Attribution CC BY 4.0 license, which allows the articles to be reused and distributed without restriction, provided that the original work is correctly cited and the authors grant the journal the right of first publication. The concepts, opinions and ideas published in the manuscripts are the sole responsibility of their author(s) and do not reflect the opinion of the journal. |
Intellectual Property and Terms of Use
|
Authors of articles published by Respiratory Research & Clinical Practice retain the copyright of their works, licensing them under the Creative Commons Attribution (CC-BY 4.0) license, which allows articles to be reused and distributed without restriction, as long as the original work is correctly cited. This journal makes articles available online as soon as possible after acceptance. This includes the proofs of the article (in HTML and PDF formats), which have undergone minor corrections after acceptance and formatting for ease of reading, but are not yet the definitive versions of the manuscript. The PDF of the article at this stage also includes a disclaimer stating that it is an unedited article. This version will be replaced in subsequent production steps. A Digital Object Identifier (DOI) is allocated to each article, making it fully citable and searchable by title, author(s) name, and full text. Respiratory Research & Clinical Practice (RRCP) encourages authors to self-archive their accepted manuscripts, publishing them in personal blogs, institutional repositories and academic social media, as well as posting them on their personal social media, provided that the full citation to the journal's website version is included. |
Sponsors and Promotion Agencies
|
Sociedade Brasileira de Pneumologia e Tisiologia |
Editor-in-Chief
|
Vice Editor-in-Chief
|
Associate Editors
|
Technical Team
|
Editorial Manager |
|
Before you submit: Please read carefully the instructions below and be sure your manuscript is compliant. This will save you time and expedite the peer-review process. Studies on Covid-19, Narrative Review, Viewpoint, and Editorials: should only be submitted if invited by the editor-in-chief. If you believe you have a manuscript in one of these formats that deserves to be evaluated by the journal, please send an e-mail to: rrcp@sbpt.org.br We do not publish case reports. Manuscripts must be submitted in English. No fees are charged for the submission, evaluation or publication of manuscripts. All articles must be submitted electronically to: https://mc04.manuscriptcentral.com/rrcp-scielo |
Types of Documents Accepted
|
In addition to following the general manuscript preparation instructions, authors should refer to the specific instructions for the type of article they are submitting.
|
Authors' Contribution
|
All listed authors must meet the four criteria for authorship outlined in the ICMJE Recommendations 2024 (http://www.ICMJE.org). These criteria are:
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND Each author should clearly outline their specific contributions to the manuscript. Additionally, any conflicts of interest should be disclosed transparently after the acknowledgments section, enabling readers to assess the potential impact of external influences on the study results. For conflict statement click here.
Data collection and subject recruitment alone do not qualify for authorship. Similarly, authorship should not be granted to technicians conducting routine tasks, referring physicians, doctors interpreting standard exams, or department heads not directly involved in the research. Contributions from these individuals may be acknowledged in a dedicated section at the end of the manuscript (before the references). The specific contributions of each author and any acknowledgments must be clearly stated on the title page (see Title Page). Assisted technologies, including Large Language Models (LLMs), chatbots, or image creators, used in the creation of submitted work must be clearly disclosed. Authors utilizing such technologies should describe their usage in both the cover letter and the appropriate sections of the manuscript, if applicable. If AI is employed for data collection, analysis, or figure generation, this must be detailed in the Methods section. Authors are encouraged to meticulously review and edit AI-generated content, as it may be incorrect, incomplete, or biased. Furthermore, authors must ensure there is no plagiarism in their work, including text and images generated by AI, and they bear full responsibility for all generated and quoted material, as well as complete citations. The RRCP does not accept images or figures that have been enhanced by AI. Any use of AI for writing assistance should be acknowledged in the acknowledgment section. |
Manuscript Preparation
|
Three files are required for the submission of an article: Author agreement, Title Page and Manuscript. Author agreement: Form on Open Science Compliance or Cover Letter in which the authors declare that the article has not been previously published (except in the form of an abstract or as part of a published academic lecture or thesis); is not being evaluated for publication elsewhere; its publication has been approved by all authors and tacitly or explicitly by the responsible authorities where the study was carried out; and, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically, without the written consent of the copyright holder.
Title page (with author details): must contain the following information: Blind manuscript (no author details): The main body of the article (including references, figures, tables, and any acknowledgments) should not include any identification, such as the authors' names or affiliations. It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Highlights such as bold, italic, subscript, superscript, etc. can be used. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. Please note that source files of figures, tables and graphs will be required whether or not you embed your figures in the text. Abstract: The abstract should state briefly the purpose of the research, the main results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, references should be avoided, but if essential, then cite the author(s) and year(s). Non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself. We kindly ask you to include the abstract within the manuscript file. The abstract should have no more than 250 words or 1,400 characters. Do not include words that could identify the institution or city where the study was performed, to facilitate blind review. The abstract should be structured as described below:
Abstract for original articles Results: Describe the most important findings, confidence intervals, and statistical significance of the findings. Conclusions: Only describe conclusions that reflect the purpose of the study and that are supported by your findings. Discuss possible applications of the findings, with equal emphasis on positive and negative findings that have similar scientific merit.
Abstract for review articles Keywords: Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Use abbreviations sparsely. These keywords will be used for indexing purposes. Please use Medical Subject Headings (MeSH), available at http://www.nlm.nih.gov/mesh/meshhome.html. When suitable descriptors are not available, new terms may be used.
Abbreviations: Acknowledgements: collate them in a separate section at the end of the article before the references. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.). Only individuals or institutions that contributed significantly to the study, but are not qualified for authorship, should be mentioned. Individuals cited in this section must agree in writing to the inclusion of their names, since readers may infer their endorsement of the conclusions of the study. Funding sources: List funding sources in a standard way to facilitate compliance to funder's requirements. Text: The main text in original articles should contain the following sections, indicated by a subtitle: Introduction, Methods, Results, and Discussion. We kindly ask that, apart from this structure, a maximum of 8 subheadings be included.
The sections in review articles may vary depending on the topic. Please submit math equations as editable text and not as images. Present simple formulae in line with normal text where possible and use a slash (/) instead of a horizontal line for small fractional terms, e.g., X/Y. Variables are to be presented in italics. Powers of " e" are often more conveniently denoted by exp. Consecutively number any equations to be displayed separately from the text (if explicitly referred to in the text). Footnotes should not be used. Instead, incorporate the relevant information into the main text. In the case of an original article, include a statement indicating that the research was approved by an institutional ethics committee. Studies involving patients or volunteers require ethics committee approval and informed consent, which must be informed in the text of the article. Relevant consents, permissions, and waivers must be obtained whenever an author wishes to include case details or other personal information or images of patients and of any other individuals. Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. CONSORT checklist and template flow diagram are available at: http://www.consort-statement.org/. Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration. In line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardize consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work. |
Article Submission Format
|
Title in English: concise and informative title. Avoid unnecessary terms and abbreviations; also avoid reference to the site and/or city where the work was carried out. Short title: title of not more than 50 characters including spaces to appear on the headers. Authors:
Conflict of interest: write “nothing to declare” or clearly disclose any financial or other interests which could cause embarrassment if revealed after the publication of the article. Corresponding author: name, postal address, telephone number and e-mail address. Funding source: institutions or suppliers of equipment and materials, if applicable. Total word count of the text: Original articles cannot exceed 3,000 words and review articles cannot exceed 5,000 words, not including abstract, acknowledgements, references, tables and legends of the figures. Abstract: The abstract must have a maximum of 250 words. Please avoid the use of abbreviations and authors' identifications. Abstract for original articles: Objective, Methods, Results, Conclusions Keywords: 3-6: Keyword 1; Keyword 2; Keyword 3. Please use Medical Subject Headings (MeSH), available at http://www.nlm.nih.gov/mesh/meshhome.html. In the case of an original article, include a statement informing that the research was approved by an institutional ethics committee. In randomized controlled trials and clinical trials, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial. Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. |
Digital Assets
|
The manuscript must include: Figures and Tables All figures and tables must be numbered according to the order mentioned in the text. Tables and figures should be inserted after the references, only one on each page, and the figures should preferably be prepared in MS Excel® or editable format in 300 DPI files. They must also have a title. Figures that require higher resolution should be sent in separate files. Figures with text must be provided in open files for translation. If this is not possible, the author must provide a translation. The quantities, units and symbols used must comply with the rules in force in the country. Figures should have captions explaining the results, allowing for understanding without consulting the text. The legends of tables and figures should be concise but self-explanatory, allowing comprehension without consulting the text. The units must be within the table, and the statistical tests must be indicated in the legend. Figures that have already been published must be accompanied by the authorization of the author/editor. The reproduction of figures, graphs, diagrams or tables that do not originally belong to the article must refer to the source. |
Citations and References
|
References should be updated. They must not contain articles that are not mentioned in the text, unpublished work or work deposited in preprint repositories. They must be numbered consecutively according to the citation sequence in the text and identified with Arabic numerals. Please use a reference manager (i.e Zotero, Mendeley or other) to ensure the adequate formatting of references. The presentation must follow the Vancouver Style format, as in the following templates. The titles of journals should be abbreviated according to the National Library of Medicine, available in the NLM Title Abbreviation (https://www.ncbi.nlm.nih.gov/nlmcatalog/journals). For all references, cite up to six authors. In the case of more than six authors, mention the first six followed by the expression “et al.” Printed articles Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, et al. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 2020;382(21):2049-55. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. Electronic articles World Health Organization (WHO). Conceptual framework for the international classification for patient safety version 1.1: final technical report January 2009. Geneva: WHO; 2009 [cited 2022 Dec 12]. Available from: https://apps.who.int/iris/handle/10665/7088212 São Paulo. Government of the State of São Paulo. Secretary of State for Health. Clinical Hospital, University of São Paulo School of Medicine. Activity report. Management Result Brightness in the Eyes. Years 2015 and 2016. [cited 2022 Jul 30]. Available in: https://www.hc.fm.usp.br/images/pdf/superintendencia/relatorios/Relatorio_Atividades_2015_2016_1.pdf Supplements Chawla R, Dixit SB, Zirpe KG, Chaudhry D, Khilnani GC, Mehta Y, et al. ISCCM Guidelines for the Use of Non-invasive Ventilation in Acute Respiratory Failure in Adult ICUs. Indian J Crit Care Med. 2020;24(Suppl 1):S61-S81. Books Hall JE. Guyton and Hall textbook of medical physiology. 13th ed. Philadelphia, PA: Elsevier; 2016. Book chapters Ricci Z, Romagnoli S. Technical complications of continuous renal replacement therapy. In: Bellomo R, Kellum JA, La Manna G, Ronco C, Editors. 40 years of continuous renal replacement therapy. Contributions to Nephrology. Basel: Karger; 2018. vol. 194, p. 99-108. |
Supplementary Documents
|
Supplementary Materials The authors may submit materials supporting the manuscript for publication as a Data Supplement to a Respiratory Research & Clinical Practice manuscript. Videos, audio files, spreadsheets, and PowerPoint files (as well as other file types) may be included in this section. Additional text, tables (and supporting information), and figures (and supporting information) may also be included. The supplementary material must be submitted simultaneously with the rest of the manuscript and will undergo peer review and be judged by the same criteria as the rest of the manuscript. The cover sheet of the material being submitted as supplementary material should give only the manuscript title, list the authors (not affiliations), and include the title “Supplementary Material.” The Editorial Office staff is not responsible for extracting supplementary material from the main manuscript for publication as supplementary material. The information included in the Data Supplement will not be copy edited or proofread by the journal staff. The figures and tables in the Supplementary Material should be labeled Figure 1S, Table 1S, and so on. To indicate the presence of these items, the author must make a statement in the main manuscript, such as “see Figure 1S in the Supplementary Material.” File Types: Authors can submit supplementary text (PDF, DOC), images (JPEG, TIFF), datasets (XLS, CSV), and videos (MP4). They also accept audio files for interviews or sound-based data. File Limits: Each file should be no larger than 10 MB to ensure accessibility, and larger files should be compressed or submitted in smaller segments. Referencing and Labeling: All supplementary materials must be numbered (e.g., "Supplementary Table 1S" or "Supplementary Figure 3S") and referenced in the corresponding place within the manuscript. A brief description of each file must also be provided. Utility: The journal stresses that supplementary material should only include data directly relevant to the article's conclusions and accessible for readers who may wish to replicate the study. Therefore, a maximum of 20 pages (including 10 tables and 10 Figures) is warranted |
Additional Information
|
Authors must submit to the journal: Cover letter - Must contain a statement attesting that the article is original and that it has not been and is not being submitted for publication in another journal. When applying, authors must declare that the study was approved by the Institutional Review Board (IRB). If necessary, during the peer review process, authors may be asked to send a copy of the IRB approval. Declaration of conflicts of interest - The conflicts of interest of all authors must be disclosed on the title page. Authors should download the appropriate form download - https://rrcpjournal.org/wp-content/uploads/sites/17/2026/02/copyright_2026.pdf ) and after signing, the corresponding author should upload it during the submission process. Funding - Information on possible sources of funding for the research is required during the submission process, as on the title page of the manuscript. Patient information - The written consent signed by the patient(s) or their guardians must be sent in the case of manuscripts that include clinical information or photographs, in which the patients may be individually identified. Clinical Trials - Submission of the clinicaltrials.gov registration number (NCT) is mandatory. |
Contact
|
Respiratory Research & Clinical Practice (RRCP) Official Journal of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)
Editorial Office |
Read our Open Access Statement
